Overview

A Study in Healthy Subjects and Mild Asthmatics to Investigate Pharmacokinetics of AZD5423 When Administered in Different Ways

Status:
Completed

Trial end date:
2011-10-01

Target enrollment:

Participant gender:

Summary

A study in healthy subjects and mild asthmatics to investigate Pharmacokinetics of AZD5423 when administered in different ways.

Phase:

Phase 1

Details

Lead Sponsor:

AstraZeneca